SQZ Biotechnologies (SQZB) Financial Statements
SQZ Biotechnologies Financial Overview
SQZ Biotechnologies's market cap is currently $707.79K. The company's EPS TTM is $-2.43; its P/E ratio is -0.01; SQZ Biotechnologies has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 21.03M | $ 27.10M | $ 21.00M | $ 20.11M | $ 12.67M |
| Gross Profit | $ 9.79M | $ 16.07M | $ 21.00M | $ 20.11M | $ 12.67M |
| Operating Income | $ -80.68M | $ -68.77M | $ -51.06M | $ -34.27M | $ -20.40M |
| EBITDA | $ -64.14M | $ -57.74M | $ -40.12M | $ -29.91M | $ -18.18M |
| Net Income | $ -79.46M | $ -68.74M | $ -50.52M | $ -32.20M | $ -20.23M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 63.71M | $ 143.51M | $ 170.36M | $ 98.28M | $ 106.91M |
| Total Assets | $ 107.19M | $ 226.15M | $ 231.14M | $ 152.35M | $ 115.55M |
| Total Debt | $ 34.37M | $ 69.69M | $ 47.09M | $ 42.33M | $ 0.00 |
| Net Debt | $ -29.34M | $ -73.82M | $ -123.26M | $ 3.08M | $ -59.57M |
| Total Liabilities | $ 50.04M | $ 102.18M | $ 103.94M | $ 93.76M | $ 52.69M |
| Stockholders' Equity | $ 57.15M | $ 123.98M | $ 127.20M | $ 58.59M | $ 62.86M |
| Cash Flow | |||||
| Free Cash Flow | $ -84.07M | $ -82.75M | $ -44.33M | $ -35.66M | $ 19.79M |
| Operating Cash Flow | $ -83.55M | $ -82.14M | $ -43.15M | $ -33.49M | $ 21.10M |
| Investing Cash Flow | $ -488.00K | $ -613.00K | $ 57.82M | $ -12.85M | $ -36.96M |
| Financing Cash Flow | $ 4.23M | $ 55.91M | $ 116.42M | $ 26.04M | $ 68.12M |
Currency in USD